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Abstract 
 
 Using radioactive in situ hybridisation, the distribution of prodynorphin mRNA in the 
brains of C57Bl/6 mice was systemically investigated, and double-labelling in situ 
hybridisation was used to determine the extent to which neuropeptide Y (NPY) and 
prodynorphin mRNAs were co-expressed. Our results demonstrate that prodynorphin mRNA 
expression in the mouse brain is localised at specific subregions of the olfactory bulb, cortex, 
hippocampus, amygdala, basal ganglia, thalamus, hypothalamus, mesencephalon and 
myelencephalon. Among the regions displaying the most intense labelling were the olfactory 
tubercle, lateral septum (LS), caudate putamen (Cpu), central amygdaloid nucleus (Ce), 
paraventricular hypothalamic nucleus (PVN), supraoptic nucleus (SO), lateral hypothalamic 
area (LHA), ventromedial hypothalamic nucleus (VMH), lateral reticular nucleus (LRt) and 
solitary tract nucleus (NTS). In the arcuate nucleus of the hypothalamus (Arc), double-
labelling in situ hybridisation revealed that prodynorphin expressing neurons also contained 
NPY mRNA, with a co-localisation rate of approximately 88% in the lateral part of the Arc, and 
79% in the dorsal part of the Arc, respectively, suggesting potential overlapping functions of 
these two neurotransmitters in feeding type behaviour. 
 
1. Introduction 
 Dynorphin was first isolated from the porcine pituitary gland (Goldstein et al., 1979), 
was later shown to be widely expressed in the central nervous system (CNS). Dynorphin is a 
member of the opioid family of peptides and exerts its action through three opioid receptors, 
namely kappa (KOR), mu (MOR) and delta (DOR) ( Curran and Watson, 1995), with greatest 
affinity for the kappa receptor. Several different types of peptides can be derived from the 
precursor peptide including dynorphin A, dynorphin B, dynorphin 32, α-neo-endorphin, and β-
neo-endorphin ( Rossier, 1982). Dynorphin peptides and their receptors are involved in a 
variety of physiological processes, including regulation of motor activity, pain modulation, 
inflammation response modulation, spinal nociception and energy balance ( Glass et al., 
1999, Palkovits, 2000 and Simonato and Romualdi, 1996). 
 The distribution of dynorphin in the CNS has been investigated by 
immunohistochemical methods in the rat (Nakao et al., 1981), hamster (Neal and Newman, 
1989) and primate (Abe et al., 1988 and Khachaturian and Watson, 1982), demonstrating 
discrete and high levels of dynorphin peptide levels in several CNS areas. Prodynorphin 
mRNA expression has also been investigated in the rat brain, showing high levels of 
expression in the hippocampus, striatum, amygdala and hypothalamus (Morris et al., 1986, 
Sato et al., 1991 and Merchenthaler et al., 1997). However, there are no studies so far 
describing the distribution and regulation of prodynorphin mRNA in the mouse brain. This is a 
fundamentally important question, because more and more research on the function of 
dynorphin or opioid receptors makes use of knockout mice models. 
 Dynorphin levels are highly regulated. For example, dynorphin immunoreactivity is 
strongly increased in the hypothalamus of rats after food deprivation and during the dark 
phase, suggesting a physiological role of dynorphin and kappa opioid receptors in regulating 
food intake ( Przewlocki et al., 1983). The same regulation of food intake can also be seen for 
another orexigenic molecule, neuropeptide Y (NPY) (Sahu et al., 1988). Interestingly, 
dynorphin has been shown to compete with specific binding sites for NPY on Y-receptors in 
vitro, suggesting that high expression of dynorphin may competitively bind to Y receptors to 
inhibit NPY signalling pathways (Miura et al., 1994). Also, intracerebroventricular injection of 
NPY or dynorphin results in a marked increase in food intake in fasted rats (Lambert et al., 
1993), demonstrating that these two peptides may play a similar role in the central control of 
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feeding behaviour. The arcuate nucleus of the hypothalamus is a key area in regulating food 
intake and energy homeostasis, where both NPY and prodynorphin mRNA are reported to be 
expressed. This further supports a major role for these two peptides in modulating of energy 
balance ( Baldock et al., 2002, Morris et al., 1986 and Sato et al., 1991). 
 In order to more directly investigate the role of hypothalamic dynorphin and NPY in 
the regulation of energy homeostasis, we have systematically mapped the distribution of 
prodynorphin mRNA expression in the mouse brain and performed co-localisation 
experiments to investigate whether NPY and prodynorphin mRNA expression overlap. 
 
2. Material and methods 
 
2.1. Animals and tissue collection 
 
 At 16 weeks of age, 18 C57Bl/6 wild type and 6 dynorphin knockout male mice were 
killed by cervical dislocation, and brains were removed and immediately frozen on dry ice. Six 
brains from wild type mice were used to map the distribution of prodynorphin mRNA and 
another six wild type brains were used to examine double labelling in situ hybridisation of 
NPY and prodynorphin mRNA in the hypothalamus. The remaining six wild type brains were 
used as controls to compare prodynorphin and NPY mRNA expression to sections from 
dynorphin knockout mouse brains. 
 
2.2. In situ hybridization 
 
 Coronal slices (20 µm) of fresh frozen brains were cut and thaw-mounted on charged 
slides and stored at −20 °C until use. For radioactive in situ hybridisation, DNA 
oligonucleotides complementary to mouse prodynorphin gene (5′-TTCAGGACGGGTTCCA- 
AGAGCTTGGCATGTGCACT GATGCCT-3′) were labelled with [35S] thio-dATP (Amersham 
Pharmacia or NEN) using terminal deoxynucleotidyltransferase (Roche, Mannheim, Germany 
or Amersham Pharmacia). The levels of prodynorphin mRNA expression were evaluated by 
measuring silver grain densities over individual neurons from photo-emulsion-dipped 
sections, as described previously (Sainsbury et al., 2002). The density of prodynorphin mRNA 
was graded as “+” (weak), “++” (moderate) or “+++” (intense). 
 
2.3. Dual labelling in situ hybridization 
 
 Dual labelling in situ hybridisation was performed by combining both radioactive and 
non-radioactive in situ hybridisation protocols. For the radioactive in situ hybridisation, the 
mouse NPY DNA oligonucleotides (5′-GAGGGTCAGTCCACACAGCCCCATTCGCTTGTTA- 
CCTAGCAT- 3′) were labelled with [35S] thio-dATP as described in Section 2.2. For the non-
radioactive in situ hybridisation, DNA oligonucleotides specific for the prodynorphin gene 
were tailed with digoxigenin at the 3′ end using terminal transferase (DIG Use’s Guide 
Manual, Boehringer Mannheim, 1995). Matching sections from the same portion of the Arc of 
dynorphin knockout and wild type control mice were used to examine prodynorphin mRNA 
expression and assayed together. The mixture of hybridisation solution consisted of 50% 
formamide, 5 × SSC (1 × SSC is 150 mM NaCl, 15 mM sodium citrate at pH 7.2), 500 µg/ml 
salmon sperm DNA, 250 µg/ml yeast tRNA, 1 × Denhardt’s solution (0.02%Ficoll, 0.02% 
polyvinylpyrrolidone, and 0.02% bovine serum albumin), 10% dextran sulfate, and 20 mM 
dithiothreitol. The 35S-labeled probe was diluted to 106 cpm/ml with the hybridisation solution, 
and the digoxigenin-labelled probe was used at a dilution of 2.5 pmol/ml. The hybridisation 
solution (100 µl) was then applied to each section and incubated for 16 h at 42 °C. The 
sections were washed twice in 2 × SSC with 50% formamide and 100 µl of 1 M dithiothreitol 
at 40 °C and twice in 2 × SSC with 50% formamide at 40 °C for 15 min each, respectively. 
Following the washes, we used the standard colorimetric detection system using NBT and X-
phosphate to detect the digoxigenin-labelling dynorphin signals (Boehringer Mannheim, 
Germany). Sections were air-dried and dipped in 3% parlodion (Sigma) dissolved in diethyl 
ether. Slides were air-dried overnight, dipped in photographic emulsion (Kodak, Rochester, 
New York) and then stored in foil-wrapped slide boxes at 4 °C for 2 weeks. Slides were 
developed with D-19 developer (Kodak, Rochester, New York), and then immersed in distilled 
water and cover-slipped with Aquamount® (Merck KGaA, Dannstadt, Germany). 
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2.4. Quantitation 
 
 Cell counting was performed using a grid reticule and the 10× objective of a Zeiss 
Axioplan light microscope (Oberkochen, Germany). Double labelled cells within the Arc were 
delineated through adjacent landmarks, according to the atlas of the mouse brain in 
stereotaxic coordinates by Franklin and Paxinos (Franklin and Paxinos, 1997). The positively 
double-labelled cells were counted if the number of silver grains overlying identified neuron 
bodies (digoxigenin-labelled) were five times higher than background levels. The values 
represent an average of positive neurons in a given area of one hemisphere from a single 
section. The average cell counts per area were determined by both left and right sides of the 
coronal sections, and then all groups were pooled for final analyses. 
 
3. Results 
 
3.1. Distribution of the prodynorphin mRNA in mouse brain 
 
 The most prominent prodynorphin mRNA expression was found in specific 
subregions of the cortex, olfactory bulb, hippocampus, amygdala, basal ganglia, thalamus, 
hypothalamus, mesencephalon and myelencephalon (Table 1). A detailed description of the 
specific localisation of prodynorphin mRNA is given below. 
 
3.2. Telencephalon 
 
 In cortical regions, moderate hybridisation signals were observed over neurons in 
cingulate and layer 3 of the piriform cortices. Low signals were seen in primary 
somatosensory, agranular insular, perirhinal, lateral entorhinal and retrosplenial cortices. 
Neurons in the olfactory bulb and anterior olfactory nucleus exhibited weak hybridisation 
signals, while intensely labelled neurons were seen in the olfactory tubercle. A large number 
of intensely labelled neurons were also observed in the caudate putamen (Fig. 4a and b), and 
moderate to highly labelled neurons were found in the nucleus accumbens (core region, 
medial and dorsal to anterior commissure). Low to moderate hybridisation signals were 
expressed in the septal area, most of which were localised at the lateral septum. In the 
hippocampus, the granular cell layer of the dentate gyrus displayed moderate hybridisation 
signals while weak signals were shown in the pyramidal cell layer throughout the 
hippocampal proper (CA1-3) and striatum lucidem of the hippocampus. 
 In the amygdala, hybridisation signals were widespread over many nuclei with 
particular intense signals found in the medial (Fig. 4c and d) and lateral parts of cental 
amygdaloid nucleus. In addition, moderate signal was seen in the posterior part of medial 
amygdaloid and basolateral amygdaloid nuclei. In the bed nucleus of the stria terminalis, the 
lateral subdivisions contained weakly labelled neurons. Caudally, amygdalalohippocampal 
areas exhibited subpopulations of moderately labelled neurons. Weak labelling was observed 
in the entopeducular nucleus and ventral pallidum. 
 
3.3. Diencephalon 
 
 In the thalamus, prodynorphin mRNA was sparsely distributed. A few neurons in the 
central medial thalamic and the medial habenular nuclei were moderately labelled, while 
small groups of neurons in the reticular nucleus and zona incerta were weakly labelled (Fig. 
1). 
 Strong labelling was observed in a number of hypothalamic nuclei (Figs. 2 and 3). 
Among these, the supraoptic nucleus (Fig. 2a and b), paraventricular (Fig. 2c and d) 
(divisions of medial, lateral magnocellular, dorsal and posterior) and ventromedial 
hypothalamic nuclei (Fig. 3a and b) exhibited the most intense hybridisation signals for 
prodynorphin mRNA. In the medial preoptic area, moderate signals of silver grains were 
observed over scattered neurons, some of which were found in the region of the 
retrachiasmatic and anterior hypothalamic areas. High to moderate hybridisation signals were 
also found in the dorsomedial (Fig. 2e and f), perifornical hypothalamic nuclei, and lateral 
hypothalamic area (Fig. 3c and d). Moderately labelled neurons were observed in the arcuate 
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hypothalamic nucleus (Fig. 3e and f). In the mamillary region, weak labelling was seen in the 
dorsal and ventral premammillary nuclei. 
 
 
York) and then stored in foil-wrapped slide boxes at
4 !C for 2 weeks. Slides were developed with D-19 devel-
oper (Kodak, Rochester, New York), and then
immersed in distilled water and cover-slipped with Aqu-
amount" (Merck KGaA, Dannstadt, Germany).
2.4. Quantitation
Cell counting was performed using a grid reticule and
the 10· objective of a Zeiss Axioplan light microscope
(Oberkochen, Germany). Double labelled cells within
the Arc were delineated through adjacent landmarks,
according to the atlas of the mouse brain in stereotaxic
coordinates by Franklin and Paxinos (Franklin and
Paxinos, 1997). The positively double-labelled cells were
counted if the number of silver grains overlying identi-
fied neuron bodies (digoxigenin-labelled) were five times
higher than background levels. The values represent an
average of positive neurons in a given area of one hemi-
sphere from a single section. The average cell counts per
area were determined by both left and right sides of the
coronal sections, and then all groups were pooled for
final analyses.
3. Results
3.1. Distribution of the prodynorphin mRNA in mouse
brain
The most prominent prodynorphin mRNA expres-
sion was found in specific subregions of the cortex,
olfactory bulb, hippocampus, amygdala, basal ganglia,
thalamus, hypothalamus, mesencephalon and myelen-
cephalon (Table 1). A detailed description of the specific
localisation of prodynorphin mRNA is given below.
3.2. Telencephalon
In cortical regions, moderate hybridisation signals
were observed over neurons in cingulate and layer 3 of
the piriform cortices. Low signals were seen in primary
somatosensory, agranular insular, perirhinal, lateral
entorhinal and retrosplenial cortices. Neurons in the
olfactory bulb and anterior olfactory nucleus exhibited
weak hybridisation signals, while intensely labelled neu-
rons were seen in the olfactory tubercle. A large number
of intensely labelled neurons were also observed in the
caudate putamen (Fig. 4a and b), and moderate to
highly labelled neurons were found in the nucleus
accumbens (core region, medial and dorsal to anterior
commissure). Low to moderate hybridisation signals
were expressed in the septal area, most of which were
localised at the lateral septum. In the hippocampus,
the granular cell layer of the dentate gyrus displayed
moderate hybridisation signals while weak signals were
Table 1
Distribution of the prodynorphin mRNA in mouse brain
Region Hybridisation signal
Telencephalon
Cortex
Cingulate + +
Primary somatosensory +
Agranular insular +
Perirhinal +
Lateral entorhinal +
Piriform + +
Retrosplenial +
Olfactory bulb +
Anterior olfactory nucleus +
Olfactory tubercle + + +
Lateral septum, ventral part +
Nucleus accumbens + +
Caudate putamen (striatum) + + +
Hippocampus
Dentate gyrus + +
CA1–CA3 +
Striatum lucidem of the hippocampus +
Amygdaloid area
Central amygdaloid nucleus, medial + + +
Central amygdaloid nucleus, lateral + + +
Medial amygdaloid nucleus, posterior + +
Basolateral amygdaloid nucleus + +
Bed nucleus of stria terminalis + +
Amygdalohippocampal area + +
Entopeducular nucleus +
Ventral pallidum +
Diencephalon
Thalamus
Central medial thalamic nucleus +
Reticular thalamic nucleus +
Medial habenular + +
Zona incerta +
Hypothalamus
Medial preoptic nucleus + +
Retrachiasmatic area + +
Supraoptic nucleus + + +
Anterior hypothalamic area + +
Paraventricular nucleus
Periventricular +
Posterior subdivisions + + +
Medial magnocellular subdivision + + +
Lateral magnocellular subdivision + + +
Dorsomedial nucleus + + +
Lateral hypothalamus + +
Perifornical nucleus + +
Ventromedial nucleus + + +
Arcuate nucleus + +
Mesencephalon and mylencephalon
Inferior colliculus +
Dorsal raphe nucleus +
Peripeduncular nucleus +
Periaqueductal gray +
Substantia nigra, lateral part +
Lateral Parabrachial nucleus +
Solitary tract nucleus + + +
Lateral reticular nucleus + + +
The level of signal is a representation of relative density of pre-
prodynorphin mRNA over individual cell groups. The density of sig-
nals was graded as ‘‘+’’ (weak), ‘‘++’’ (moderate) or ‘‘+++’’ (intense).
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shown in the pyramidal cell layer throughout the hippo-
campal proper (CA1-3) and striatum lucidem of the
hippocampus.
In the amygdala, hybridisation signals were wide-
spread over many nuclei with particular intense signals
found in the medial (Fig. 4c and d) and lateral parts
of cental amygdaloid nucleus. In addition, moderate sig-
nal was seen in the posterior part of medial amygdaloid
and basolateral amygdaloid nuclei. In the bed nucleus of
the stria terminalis, the lateral subdivisions contained
weakly labelled neurons. Caudally, amygdalalohippo-
campal areas exhibited subpopulations of moderately
labelled neurons. Weak labelling was observed in the
entopeducular nucleus and ventral pallidum.
3.3. Diencephalon
In the thalamus, prodynorphin mRNA was sparsely
distributed. A few neurons in the central medial
thalamic and the medial habenular nuclei were moder-
ately labelled, while small groups of neurons in the retic-
ular nucleus and zona incerta were weakly labelled
(Fig. 1).
Strong labelling was observed in a number of hypo-
thalamic nuclei (Figs. 2 and 3). Among these, the supra-
optic nucleus (Fig. 2a and b), paraventricular (Fig. 2c
and d) (divisions of medial, lateral magnocellular, dorsal
and posterior) and ventromedial hypothalamic nuclei
(Fig. 3a and b) exhibited the most intense hybridisation
signals for prodynorphin mRNA. In the medial preoptic
area, moderate signals of silver grains were observed
over scattered neurons, some of which were found in
the region of the retrachiasmatic and anterior hypotha-
lamic areas. High to moderate hybridisation signals
were also found in the dorsomedial (Fig. 2e and f), per-
ifornical hypothalamic nuclei, and lateral hypothalamic
area (Fig. 3c and d). Moderately labelled neurons were
observed in the arcuate hypothalamic nucleus (Fig. 3e
and f). In the mamillary region, weak labelling was seen
in the dorsal and ventral premammillary nuclei.
3.4. Mesencephalon and mylencephalon
Few regions of the midbrain and hindbrain were
shown to contain significant levels of prodynorphin
mRNA (Table 1, Fig. 4). Sporadic positive neurons were
Fig. 1. Autoradiograms of prodynorphin mRNA expression in the mouse. The slides containing coronal mouse brain sections are presented in
rostrocaudal sequence. Some major neuroanatomical landmarks are indicated on the right side of each autoradiogram. Abbreviations: AO, anterior
olfactory nucleus; AcbC, nucleus accumbens; Arc, accurate hypothalamic nucleus; Ce, central amygdaloid nucleus; Cpu, caudate/putamen; DG,
dentate gyrus; DMH, dorsomedial hypothalamic nucleus; LEnt, lateral entorhinal cortex; LH, lateral hypothalamic area; LRt, lateral reticular
nucleus; NTS, nucleus of the solitary tract; Pir, piriform cortex; PVN, paraventricular hypothalamic nucleus; RSA, retrosplential cortex; SO,
supraoptic nucleus; Tu, olfactory tubercle; VMH, ventromedial hypothalamic nucleus. Magnification, 10·.
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evident in the inferior colliculus, dorsal raphe nucleus,
peripeduncular nucleus and periaqueductal gray. The
lateral part of substantia nigra and parabrachial nucleus
were observed only a very scattered prodynorphin
mRNA. The solitary tract nucleus (Fig. 4e and f) and
lateral reticular nucleus contained intensely labelled
cells.
3.5. Co-localisation of NPY and prodynorphin mRNA in
the hypothalamus
In order to investigate the possible interaction of
dynorphin with the NPY system we performed double-
labelling experiments employing NPY 35S-labelled and
prodynorphin-digoxigenin-labelled probes. The largest
numbers of co-expressing neurons were found in the
Arc (Fig. 5c and d). NPY mRNA was co-expressed in
approximately 80% of Arc dynorphin neurons (79%
located in the dorsal part of Arc and 88% located in lat-
eral part of Arc). No co-localisation of NPY and dynor-
phin could be detected in any other hypothalamic nuclei
(data not shown), however, several other parts of the
brain including the central amygdala (approx 30%),
the posterior part of the medial amygdala (approx
25%) and the caudata putamen (approx 25%) show co-
localisation of NPY and dynorphin mRNA. As a con-
trol, no prodynorphin mRNA expression was shown
in the Arc of dynorphin knockout mice (Fig. 5b). Inter-
estingly, the NPY mRNA expression level in the arc of
dynorphin knockout mice was reduced by approxi-
mately 26% (Fig. 6) further suggesting a close interac-
tion between these two neurotransmitter systems.
4. Discussion
This study shows for the first time that Arc NPY neu-
rons contain prodynorphin mRNA. Previously, it has
been known that peripherally administrated leptin
induces c-fos expression in dynorphin positive neurons
in the Arc, suggesting that like NPY, dynorphin is also
regulated by leptin (Elias et al., 2000). This is supported
Fig. 2. Emulsion-dipped autoradiographs of prodynorphin mRNA expression of in the hypothalamus. (a),(c) and (e): brightfield low-magnification
micrograph of the supraoptic nucleus, paraventricular hypothalamic nucleus and dorsomedial hypothalamic nucleus, respectively. (b),(d) and (f): a
high-magnification of micrograph of the supraoptic nucleus, paraventricular hypothalamic nucleus and dorsomedial hypothalamic nucleus,
respectively; 3 V, the third ventricle; SO, supraoptic nucleus; PVN, paraventricular hypothalamic nucleus; DMH, dorsomedial hypothalamic nucleus;
Scale bars = 40 lm in (a),(c) and (e), and 25 lm in (b),(d) and (f).
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3.4. Mesencephalon and mylencephalon 
  
 Few regions of the midbrain and hindbrain were shown to contain significant levels of 
prodynorphin mRNA (Table 1, Fig. 4). Sporadic positive neurons were evident in the inferior 
colliculus, dorsal raphe nucleus, peripeduncular nucleus and periaqueductal gray. The lateral 
part of substantia nigra and parabrachial nucleus were observed only a very scattered 
prodynorphin mRNA. The solitary tract nucleus (Fig. 4e and f) and lateral reticular nucleus 
contained intensely labelled cells. 
 
 
 
by the fact that after food deprivation, both NPY and
prodynorphin mRNA are significant increased in the
hypothalamus (Przewlocki et al., 1983; Sahu et al.,
1988). Furthermore, prodynorphin mRNA expression
is increased five-fold in the DMN of leptin deficient
ob/ob mice (Khawaja et al., 1991), the DMN being a
region that shows intense dynorphin expression in the
mouse. Therefore, it is possible that dynorphin and
NPY interact within the hypothalamus in the regulation
of foo intake and energy hom ostasis.
The present study also demonstrates a conserved
expression pattern for the prodynorphin mRNA in the
mouse brain compared to rats. The regions that exhib-
ited highest hybridisation signals for prodynorphin
mRNA include the olfactory tubercle, caudate putamen,
sub-group of the amygdala, most of the hypothalamic
nuclei, and several brain stem nuclei. However, there
were also diﬀerences found between the prodynorphin
mRNA expression in the mouse to that of the rat, par-
ticularly in the central amygdaloid and the lateral retic-
ular nucleus which displayed intense signals in the
mouse, but only low to moderate signals in the rat
(Merchenthaler et al., 1997).
Overall our results are consistent with immu ohisto-
chemistry studies investigating the distribution of
dynorphin neurons in the rat brain (Fallon and Leslie,
1986). In the striatal region, we found the strongest
prodynorphin mRNA expressio in the olfactory tuber-
cle, caudate putamen and nucleus accumbens. Previous
studies show that prodynorphin mRNA is expressed in
GABAergic neurons in the stratum, projecting to the
substantia nigra and pallidum (Graybiel, 1986), and
that dynorphin gene expression is controlled by the
dopaminergic (Morris et al., 1988) and serotoninergic
systems (Morris et al., 1988). The nucleus accumbens
receive inputs mainly from the limbic system, which
then sends outputs to the ventral pallidum and ventral
tegmental area. Strong dynorphin signal was displayed
in the striatal region, suggesting that dynorphin may
play a role in the regulation of adaptive behavioural
response, stress, drug abuse, obsessive compulsive dis-
orders, seizures and psychoses (Laughlin et al., 2001;
Fig. 3. Emulsion-dipped autoradiographs of the expression of prodynorphin mRNA in the hypothalamus. (a),(c) and (e): brightfield low-
magnification micrograph of the ventromedial hypothalamic nucleus, lateral hypothalamic area and arcuate hypothalamic nucleus. (b),(d) and (f): a
high-magnification of micrograph of the ventromedial hypothalamic nucleus, lateral hypothalamic area and arcuate hypothalamic nucleus; 3 V, the
third ventricle. VMH, ventromedial hypothalamic nucleus; LHA, lateral hypothalamic area; Arc, accurate hypothalamic nucleus; Scale bars = 40 lm
in (a),(c) and (e), and 25 lm in (b),(d) and (f).
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Shippenberg and Rea, 1997; Shirayama et al., 2004;
Simonato and Romualdi, 1996).
Our results show high levels of prodynorphin mRNA
expression in the dentate gyrus of the mouse brain,
which supports previous reports that dynorphin-derived
peptides are synthesised in the granule cells of the den-
tate gyrus in rats, which is then transported to the axon
terminals in the C3 region of the hippocampus (Morris
and Johnston, 1995). High levels of dynorphin in the
dentate gyrus have been suggested to be involved in sei-
zures as well as addictive drug and alcohol-seeking
behaviour (Cowen et al., 1998; Morris and Johnston,
1995; Romualdi et al., 1991). In the amygdala area,
there are intense to moderate hybridisation signals in
several subregions such as the central amygdala, bed
nucleus of stria terminals and basolateral amygdaloid
nucleus suggesting an involvement of dynorphin in
mood disorders, depression and stress-related changes
in pain sensitivity (Hurd, 2002; Schulz et al., 1996). Here
we also show that there are high level of prodynorphin
mRNA expression in the NTS and lateral reticular
nucleus, which provide both ascending innervations to
the hypothalamus and descending projections to the
spinal cord. Both of these nuclei are also strategically
located in brain regions that have long been associated
with the regulation of autonomic functions such as the
cardiovascular, respiratory and nociceptive control
mechanisms.
In addition, strong prodynorphin mRNA expression
is found in the PVN and SO. In the PVN, intense prody-
norphin mRNA expression is shown in the posterior
PVN as well as the medial and lateral magnocellular
part of the PVN. Co-localisation of dynorphin and oxy-
tocin or vasopressin neurons in the magnocellular neu-
rons of the PVN and SO has been reported (Meister
et al., 1990), suggesting an important role for dynorphin
in the control of prolactin secretion and water homeo-
stasis. In addition, colocalisation of prodynorphin with
two other neuropeptides (Cocaine and amphetamine
regulated transcript and Orexin), which play an impor-
tant role in the regulation of feeding behaviour, has been
shown in the PVN and SON (Elias et al., 2001), as well
Fig. 4. Emulsion-dipped autoradiographs of the expression of prodynorphin mRNA in the caudate/putamen, central amygdaloid nucleus and
nucleus of the solitary tract. (a),(c) and (e): low-magnification micrograph of the caudate/putamen, central amygdaloid nucleus and nucleus of the
solitary tract. (b),(d) and (f): a high-magnification of micrograph of the caudate/putamen, central amygdaloid nucleus and nucleus of the solitary
tract; LV, the lateral ventricle; 4 V, the fourth ventricle; Ce, central amygdaloid nucleus; Cpu, caudate/putamen; NTS, nucleus of the solitary tract;
Scale bars = 40 lm in (a),(c) and (e), and 25 lm in (b),(d) and (f).
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3.5. Co-localisation of NPY and prodynorphin mRNA in the hypothalamus 
 
 In order to investigate the possible interaction of dynorphin with the NPY system we 
performed double-labelling experiments employing NPY 35S-labelled and prodynorphin-
digoxigenin-labelled probes. The largest numbers of co-expressing neurons were found in the 
Arc (Fig. 5c and d). NPY mRNA was co-expressed in approximately 80% of Arc dynorphin 
neurons (79% located in the dorsal part of Arc and 88% located in lateral part of Arc). No co-
localisation of NPY and dynorphin could be detected in any other hypothalamic nuclei (data 
not shown), however, several other parts of the brain including the central amygdala (approx 
30%), the posterior part of the medial amygdala (approx 25%) and the caudata putamen 
(approx 25%) show co-localisation of NPY and dynorphin mRNA. As a control, no 
prodynorphin mRNA expression was shown in the Arc of dynorphin knockout mice (Fig. 5b). 
Interestingly, the NPY mRNA expression level in the arc of dynorphin knockout mice was 
reduced by approximately 26% (Fig. 6) further suggesting a close interaction between these 
two neurotransmitter systems. 
 
 
 
4. Discussion 
 
 This study shows for the first time that Arc NPY neurons contain prodynorphin 
mRNA. Previously, it has been known that peripherally administrated leptin induces c-fos 
expression in dynorphin positive neurons in the Arc, suggesting that like NPY, dynorphin is 
also regulated by leptin (Elias et al., 2000). This is supported by the fact that after food 
deprivation, both NPY and prodynorphin mRNA are significant increased in the hypothalamus 
(Przewlocki et al., 1983 and Sahu et al., 1988). Furthermore, prodynorphin mRNA expression 
as in the parvicellular neurons in the LH (Smart and Jer-
man, 2002).
We also demonstrate co-localisation of prodynorphin
mRNA with NPY in several brain areas. Whereas co-
expression in diﬀerent parts of the amygdala indicate
overlapping or coordinated function in anxiety-related
behaviours th highest extend of overl p of NPY and
ynorphin is found in neurons of the Arc. This supports
a potential coordinated function of dynorphin and NPY
in the modulation of energy homeostasis and neuroen-
docrine regulation. Further evidence for this comes from
the observed down regulation of NPY mRNA in dynor-
phin knockout mice.
In summary, the present study provides a precise
map of prodynorphin mRNA expression and co-
expression with NPY in the mouse brain, which will
facilitate interpretation and design of dynorphin or
opioid receptors knockout and conditional knockout
studies in mice.
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Fig. 6. Emulsion-dipped autoradiographs of the expression of NPY mRNA in the arcuate hypothalamic nucleus of (a): wild type and (b): dynorphin
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bars = 40 lm.
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is increased five-fold in the DMN of leptin deficient ob/ob mice ( Khawaja et al., 1991), the 
DMN being a region that shows intense dynorphin expression in the mouse. Therefore, it is 
possible that dynorphin and NPY interact within the hypothalamus in the regulation of food 
intake and energy homeostasis. 
 The present study also demonstrates a conserved expression pattern for the 
prodynorphin mRNA in the mouse brain compared to rats. The regions that exhibited highest 
hybridisation signals for prodynorphin mRNA include the olfactory tubercle, caudate putamen, 
sub-group of the amygdala, most of the hypothalamic nuclei, and several brain stem nuclei. 
However, there were also differences found between the prodynorphin mRNA expression in 
the mouse to that of the rat, particularly in the central amygdaloid and the lateral reticular 
nucleus which displayed intense signals in the mouse, but only low to moderate signals in the 
rat (Merchenthaler et al., 1997). 
 Overall our results are consistent with immunohistochemistry studies investigating the 
distribution of dynorphin neurons in the rat brain (Fallon and Leslie, 1986). In the striatal 
region, we found the strongest prodynorphin mRNA expression in the olfactory tubercle, 
caudate putamen and nucleus accumbens. Previous studies show that prodynorphin mRNA 
is expressed in GABAergic neurons in the stratum, projecting to the substantia nigra and 
pallidum (Graybiel, 1986), and that dynorphin gene expression is controlled by the 
dopaminergic (Morris et al., 1988) and serotoninergic systems (Morris et al., 1988). The 
nucleus accumbens receive inputs mainly from the limbic system, which then sends outputs 
to the ventral pallidum and ventral tegmental area. Strong dynorphin signal was displayed in 
the striatal region, suggesting that dynorphin may play a role in the regulation of adaptive 
behavioural response, stress, drug abuse, obsessive compulsive disorders, seizures and 
psychoses (Laughlin et al., 2001, Shippenberg and Rea, 1997, Shirayama et al., 
2004 and Simonato and Romualdi, 1996). 
 Our results show high levels of prodynorphin mRNA expression in the dentate gyrus 
of the mouse brain, which supports previous reports that dynorphin-derived peptides are 
synthesised in the granule cells of the dentate gyrus in rats, which is then transported to the 
axon terminals in the C3 region of the hippocampus (Morris and Johnston, 1995). High levels 
of dynorphin in the dentate gyrus have been suggested to be involved in seizures as well as 
addictive drug and alcohol-seeking behaviour (Cowen et al., 1998, Morris and Johnston, 
1995 and Romualdi et al., 1991). In the amygdala area, there are intense to moderate 
hybridisation signals in several subregions such as the central amygdala, bed nucleus of stria 
terminals and basolateral amygdaloid nucleus suggesting an involvement of dynorphin in 
mood disorders, depression and stress-related changes in pain sensitivity (Hurd, 
2002 and Schulz et al., 1996). Here we also show that there are high level of prodynorphin 
mRNA expression in the NTS and lateral reticular nucleus, which provide both ascending 
innervations to the hypothalamus and descending projections to the spinal cord. Both of these 
nuclei are also strategically located in brain regions that have long been associated with the 
regulation of autonomic functions such as the cardiovascular, respiratory and nociceptive 
control mechanisms. 
 In addition, strong prodynorphin mRNA expression is found in the PVN and SO. In 
the PVN, intense prodynorphin mRNA expression is shown in the posterior PVN as well as 
the medial and lateral magnocellular part of the PVN. Co-localisation of dynorphin and 
oxytocin or vasopressin neurons in the magnocellular neurons of the PVN and SO has been 
reported (Meister et al., 1990), suggesting an important role for dynorphin in the control of 
prolactin secretion and water homeostasis. In addition, colocalisation of prodynorphin with 
two other neuropeptides (Cocaine and amphetamine regulated transcript and Orexin), which 
play an important role in the regulation of feeding behaviour, has been shown in the PVN and 
SON (Elias et al., 2001), as well as in the parvicellular neurons in the LH (Smart and Jerman, 
2002). 
 We also demonstrate co-localisation of prodynorphin mRNA with NPY in several 
brain areas. Whereas co-expression in different parts of the amygdala indicate overlapping or 
coordinated function in anxiety-related behaviours the highest extend of overlap of NPY and 
dynorphin is found in neurons of the Arc. This supports a potential coordinated function of 
dynorphin and NPY in the modulation of energy homeostasis and neuroendocrine regulation. 
Further evidence for this comes from the observed down regulation of NPY mRNA in 
dynorphin knockout mice. 
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 In summary, the present study provides a precise map of prodynorphin mRNA 
expression and co-expression with NPY in the mouse brain, which will facilitate interpretation 
and design of dynorphin or opioid receptors knockout and conditional knockout studies in 
mice. 
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